| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cue Biopharma, Inc. (CUE) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. CUE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.88M | $65.63M | - | |
| Other | 125.0K | $4.38M | - | |
| VP | 70.0K | $2.45M | - | |
| Other | 50.0K | $1.75M | - | |
| Dir | 24.4K | $854.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2018 | Marlett Christopher A | Director | Buy | 3,664 | $5.20 | $19,052.80 | +17.7% | |
| Dec 17, 2018 | Digiandomenico Anthony | Director | Buy | 10,000 | $5.48 | $54,800.00 | New | |
| Dec 13, 2018 | Marlett Christopher A | Director | Buy | 10,000 | $5.06 | $50,600.00 | +93.2% | |
| Dec 12, 2018 | Marlett Christopher A | Director | Buy | 12,189 | $5.08 | $61,978.23 | +161.6% | |
| Dec 11, 2018 | Marlett Christopher A | Director | Buy | 7,543 | $4.86 | $36,658.98 | New | |
| Aug 29, 2018 | Millar Kerri-Ann | Vp-finance | Buy | 1,000 | $8.48 | $8,480.00 | New | |
| Aug 16, 2018 | Passeri Daniel R | CEO And President | Buy | 6,000 | $8.09 | $48,510.00 | +14.4% | |
| Jun 29, 2018 | Passeri Daniel R | CEO And President | Buy | 1,600 | $11.97 | $19,152.00 | +4.0% | |
| Dec 27, 2017 | Pienta Kenneth | Chief Medical Officer | Buy | 2,000 | $7.50 | $15,000.00 | New |